CN105441387A - 亚全能干细胞专用培养基及其专用培养方法 - Google Patents
亚全能干细胞专用培养基及其专用培养方法 Download PDFInfo
- Publication number
- CN105441387A CN105441387A CN201410446098.3A CN201410446098A CN105441387A CN 105441387 A CN105441387 A CN 105441387A CN 201410446098 A CN201410446098 A CN 201410446098A CN 105441387 A CN105441387 A CN 105441387A
- Authority
- CN
- China
- Prior art keywords
- green algae
- blue green
- subaerial blue
- cell
- special culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 19
- 239000001963 growth medium Substances 0.000 title claims abstract description 18
- 238000012136 culture method Methods 0.000 title abstract 2
- 210000002966 serum Anatomy 0.000 claims abstract description 12
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 7
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 7
- 238000012258 culturing Methods 0.000 claims abstract description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims abstract description 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims abstract description 4
- 229960003957 dexamethasone Drugs 0.000 claims abstract description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims abstract description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241000192700 Cyanobacteria Species 0.000 claims description 39
- 210000004027 cell Anatomy 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 20
- 238000005138 cryopreservation Methods 0.000 claims description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 238000007710 freezing Methods 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 12
- 230000029087 digestion Effects 0.000 claims description 11
- 230000010261 cell growth Effects 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000012679 serum free medium Substances 0.000 claims description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 3
- 102000013275 Somatomedins Human genes 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 238000004820 blood count Methods 0.000 claims description 3
- 210000001772 blood platelet Anatomy 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 229960004232 linoleic acid Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 7
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 abstract 1
- 101800003838 Epidermal growth factor Proteins 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- 229930182816 L-glutamine Natural products 0.000 abstract 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 abstract 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 abstract 1
- 229940116977 epidermal growth factor Drugs 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000003954 umbilical cord Anatomy 0.000 description 2
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000002444 unipotent stem cell Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410446098.3A CN105441387B (zh) | 2014-09-03 | 2014-09-03 | 亚全能干细胞专用培养基及其专用培养方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410446098.3A CN105441387B (zh) | 2014-09-03 | 2014-09-03 | 亚全能干细胞专用培养基及其专用培养方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105441387A true CN105441387A (zh) | 2016-03-30 |
CN105441387B CN105441387B (zh) | 2019-01-25 |
Family
ID=55552027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410446098.3A Active CN105441387B (zh) | 2014-09-03 | 2014-09-03 | 亚全能干细胞专用培养基及其专用培养方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105441387B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106190968A (zh) * | 2016-08-04 | 2016-12-07 | 领航干细胞再生医学工程有限公司 | 人脂肪亚全能干细胞的分离培养方法和干细胞库的构建方法 |
CN106190946A (zh) * | 2016-07-19 | 2016-12-07 | 安徽惠恩生物科技股份有限公司 | 一种用于干细胞扩增的培养基 |
CN106222130A (zh) * | 2016-08-08 | 2016-12-14 | 安徽惠恩生物科技股份有限公司 | 一种提高亚全能干细胞增殖速度的培养基 |
CN112616831A (zh) * | 2021-01-09 | 2021-04-09 | 宋文海 | 一种诱导性多能干细胞保存液及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1792979A1 (en) * | 2005-12-01 | 2007-06-06 | Stiftung Caesar Center of Advanced European Studies and Research | Cell culture system for the enrichment and expansion of stem cells |
CN101712947A (zh) * | 2009-11-12 | 2010-05-26 | 浙江大学 | 来源于胚胎干细胞的间充质干细胞的制备方法及其用途 |
CN101748096A (zh) * | 2008-12-17 | 2010-06-23 | 北京汉氏联合生物技术有限公司 | 亚全能干细胞、其制备方法及其用途 |
CN102757936A (zh) * | 2012-06-15 | 2012-10-31 | 江苏瑞思坦生物科技有限公司 | 人脂肪干细胞增殖促进剂及其应用方法 |
CN102920735A (zh) * | 2012-11-14 | 2013-02-13 | 青岛奥克生物开发有限公司 | 一种间充质干细胞注射液及其制备方法和在制备治疗糖尿病药物中的应用 |
CN103966159A (zh) * | 2014-02-13 | 2014-08-06 | 天津和泽干细胞科技有限公司 | 人胎盘亚全能干细胞及其干细胞库构建方法 |
-
2014
- 2014-09-03 CN CN201410446098.3A patent/CN105441387B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1792979A1 (en) * | 2005-12-01 | 2007-06-06 | Stiftung Caesar Center of Advanced European Studies and Research | Cell culture system for the enrichment and expansion of stem cells |
CN101748096A (zh) * | 2008-12-17 | 2010-06-23 | 北京汉氏联合生物技术有限公司 | 亚全能干细胞、其制备方法及其用途 |
CN101712947A (zh) * | 2009-11-12 | 2010-05-26 | 浙江大学 | 来源于胚胎干细胞的间充质干细胞的制备方法及其用途 |
CN102757936A (zh) * | 2012-06-15 | 2012-10-31 | 江苏瑞思坦生物科技有限公司 | 人脂肪干细胞增殖促进剂及其应用方法 |
CN102920735A (zh) * | 2012-11-14 | 2013-02-13 | 青岛奥克生物开发有限公司 | 一种间充质干细胞注射液及其制备方法和在制备治疗糖尿病药物中的应用 |
CN103966159A (zh) * | 2014-02-13 | 2014-08-06 | 天津和泽干细胞科技有限公司 | 人胎盘亚全能干细胞及其干细胞库构建方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106190946A (zh) * | 2016-07-19 | 2016-12-07 | 安徽惠恩生物科技股份有限公司 | 一种用于干细胞扩增的培养基 |
CN106190968A (zh) * | 2016-08-04 | 2016-12-07 | 领航干细胞再生医学工程有限公司 | 人脂肪亚全能干细胞的分离培养方法和干细胞库的构建方法 |
CN106222130A (zh) * | 2016-08-08 | 2016-12-14 | 安徽惠恩生物科技股份有限公司 | 一种提高亚全能干细胞增殖速度的培养基 |
CN112616831A (zh) * | 2021-01-09 | 2021-04-09 | 宋文海 | 一种诱导性多能干细胞保存液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105441387B (zh) | 2019-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Abecasis et al. | Expansion of 3D human induced pluripotent stem cell aggregates in bioreactors: bioprocess intensification and scaling-up approaches | |
CN103396990B (zh) | 一种制备间充质干细胞的方法 | |
Wang et al. | Magnetic induction heating of superparamagnetic nanoparticles during rewarming augments the recovery of hUCM-MSCs cryopreserved by vitrification | |
CN103805562B (zh) | 培养胎盘间充质干细胞的无血清培养基 | |
Dong-Rui et al. | Methods of isolation, expansion, differentiating induction and preservation of human umbilical cord mesenchymal stem cells | |
CN104560870B (zh) | 一种制备蜕膜间充质干细胞的方法 | |
CN103205396B (zh) | 一种hek-293t细胞的悬浮驯化和无血清驯化方法 | |
CN102676451B (zh) | 从胎盘中分离间充质干细胞的方法 | |
CN105441387A (zh) | 亚全能干细胞专用培养基及其专用培养方法 | |
McGuckin et al. | Potential for access to embryonic‐like cells from human umbilical cord blood | |
CN105132375A (zh) | 一种肝癌干细胞的无血清培养基及其培养方法 | |
CN105062959A (zh) | 一种人羊膜间充质干细胞的分离培养方法 | |
CN104560869A (zh) | 一种制备绒毛膜间充质干细胞的方法 | |
CN104560871A (zh) | 经血间充质干细胞的培养方法 | |
CN103013911A (zh) | 贴壁密度梯度法联合egf培养人脐带间充质干细胞的方法 | |
Spinelli et al. | Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs) | |
CN106222134A (zh) | 高效获取脂肪间充质干细胞的培养方法 | |
CN104630142B (zh) | 一种牛脐带间充质干细胞的分离及培养方法 | |
CN103952374A (zh) | 人多能干细胞培养基及人多能干细胞的培养方法 | |
CN105925523A (zh) | 一种赤眼鳍条细胞系及其建立方法与应用 | |
CN106834223B (zh) | 诱导脐带间充质干细胞向软骨细胞分化的方法 | |
CN103966166A (zh) | 尿液细胞培养基及尿液细胞的培养方法 | |
CN108265025A (zh) | 一种人类诱导多能干细胞的重编程培养基 | |
CN104928250A (zh) | 永生化奶牛乳腺上皮细胞系及其构建方法和应用 | |
CN103305453A (zh) | 一种脐带间充质干细胞的微载体培养系统 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 361001 10 building, Conley financial building, 9 Yilan Road, Siming District, Xiamen, Fujian. Applicant after: Huang Fulai Address before: 351152 Yue Pu 200, Yue Pu village, Yue Tang Township, Xiuyu District, Putian, Fujian Applicant before: Huang Fulai |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210121 Address after: Unit A-7, 431, 4 / F, building C, Xiamen international shipping center, 93 Xiangyu Road, Xiamen area, China (Fujian) pilot Free Trade Zone, Xiamen City, Fujian Province 361000 Patentee after: Juwei cell (Xiamen) Medical Technology Co.,Ltd. Address before: 361001 10 building, Conley financial building, 9 Yilan Road, Siming District, Xiamen, Fujian. Patentee before: Huang Fulai |